Shilpa Medicare gains on entering into strategic partnership with NXI Therapeutics AG
Mumbai, February 13 (Udaipur Kiran): Shilpa Medicare is currently trading at Rs. 329.00, up by 5.70 points or 1.76% from its previous closing of Rs. 323.30 on the…
Mumbai, February 13 (Udaipur Kiran): Shilpa Medicare is currently trading at Rs. 329.00, up by 5.70 points or 1.76% from its previous closing of Rs. 323.30 on the…
(Udaipur Kiran News): Shares of Shilpa Medicare climbed over 2% in Tuesday’s trade after the company received initial authorization from the European…
Shilpa Medicare has introduced Capecitabine 1000 MG dispersible tablet for the first time in the world, with novel technology of faster dispersion…
Shilpa Medicare is currently trading at Rs. 418.35, up by 20.25 points or 5.09% from its previous closing of Rs. 398.10 on…
Shilpa Medicare’s Pemetrexed Injection 1000 mg/100 ml, 500 mg/50 ml & 100 mg/10 ml, Ready to use formulation is approved by European…
Shilpa Medicare is currently trading at Rs. 531.00, up by 14.75 points or 4.21% from its previous closing of Rs. 516.25 on…
Shilpa Medicare is currently trading at Rs. 501.30, up by 45.95 points or 10.09% from its previous closing of Rs. 455.35 on…